Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
, stem cell biology, and colon cancer. Position Status Full Time Posting Number 26FA0353 Posting Open Date 04/14/2026 Posting Close Date Qualifications Minimum Education and Experience PhD training is
-
decisions, cellular heterogeneity, progenitor/stem cell regulation, and how normal homeostasis goes awry during a diverse range of diseases. We are interested in receiving applications from individuals with
-
, mesenchymal stem cells and patient‑derived chondrocytes. You will join Newcastle University’s Faculty of Medical Sciences, with access to state-of-the-art facilities and specialist training in genomics
-
mouse handling, cell culture, NGS & NGS data analysis, stem cell culture Key Competencies and Educational Requirements: PhD degree in domain discipline or related field At least 10 years of relevant
-
Professor/ Director of Allogeneic Stem Cell Transplantation - 39550 Faculty Description University of Colorado Anschutz Department: SOM-MED-BoneMarrow Transplant – Cellular Therapies Job Title
-
, aiming to identify nutrient therapeutic strategies for age-related bone and blood diseases. We also aim to understand adult stem cells in ageing and regeneration. The successful candidate will employ a
-
technical advice to more junior members of the team when appropriate Please click here for full job description About you PhD in Developmental Biology, Stem Cell or Cancer Biology or in the final stages
-
motivated and highly ambitious scientist with the following qualifications: PhD in molecular biology and/or stem cell biology and hematopoiesis. Expertise in molecular biology techniques, mouse models
-
-ON-BRAIN (https://cordis.europa.eu/project/id/101227124 ) Project Reference: 101227124 Application deadline: 15/05/2026 Position Overview One PhD position is available in the µOrganoLab at the Institute
-
AD, yet the mechanisms through which it shapes immune responses in the human brain remain poorly understood. This PhD project aims to uncover how genetic risk influences immune cell function in AD by